InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 285.90
-8.50 (-2.89%)
Jun 9, 2026, 5:05 PM IDT
InterCure Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -35.71 | -67.8 | -61.96 | 44.82 | 4.69 |
Depreciation & Amortization | 17.15 | 15.37 | 13.17 | 11.7 | 7.39 |
Loss (Gain) From Sale of Assets | 3.27 | -0.93 | 0.41 | - | - |
Asset Writedown & Restructuring Costs | - | - | 67.69 | - | - |
Loss (Gain) From Sale of Investments | 2.15 | -0.37 | 0.66 | 0.17 | 1.87 |
Stock-Based Compensation | 2.43 | 2.28 | 2.59 | 8.91 | 6.45 |
Other Operating Activities | 8.68 | -6.29 | 12.65 | -11.31 | 11.39 |
Change in Accounts Receivable | 30.84 | 8.43 | -23.49 | -18.29 | 8.39 |
Change in Inventory | 10.98 | -13.24 | 34.66 | -75.19 | -15.48 |
Change in Accounts Payable | -8.82 | -8.9 | -47.63 | 57.03 | 2.79 |
Change in Other Net Operating Assets | -14.13 | 4.52 | -54.72 | 33.42 | 2.64 |
Operating Cash Flow | 16.84 | -66.93 | -53.63 | 51.27 | 30.14 |
Operating Cash Flow Growth | - | - | - | 70.12% | 281.65% |
Capital Expenditures | -3.55 | -4.38 | -2.62 | -19.74 | -14.03 |
Sale of Property, Plant & Equipment | - | - | 0.03 | - | - |
Cash Acquisitions | -0.11 | 1.11 | -4.2 | -14.48 | -22.59 |
Divestitures | 2.43 | -0.25 | - | - | - |
Sale (Purchase) of Intangibles | - | -0.45 | - | - | - |
Investment in Securities | -0.65 | - | - | - | -1.25 |
Other Investing Activities | 0.24 | 8.59 | 5.44 | 6.96 | -20 |
Investing Cash Flow | -1.99 | 17.69 | 4.77 | -142.5 | -65.21 |
Long-Term Debt Issued | 21.15 | 188.44 | 62.73 | 263.47 | 75.46 |
Total Debt Issued | 21.15 | 188.44 | 62.73 | 263.47 | 75.46 |
Long-Term Debt Repaid | -50.28 | -180.7 | -124.71 | -125.74 | -9.63 |
Net Debt Issued (Repaid) | -29.13 | 7.74 | -61.98 | 137.73 | 65.83 |
Issuance of Common Stock | 1.5 | 34 | - | - | 137.23 |
Other Financing Activities | -19.03 | -15.29 | -20.91 | -17.28 | -5.12 |
Financing Cash Flow | -46.66 | 26.46 | -82.89 | 120.45 | 197.94 |
Foreign Exchange Rate Adjustments | -0.04 | -0.04 | 0.3 | 7.16 | -4.54 |
Net Cash Flow | -31.85 | -22.82 | -131.45 | 36.37 | 158.33 |
Free Cash Flow | 13.29 | -71.3 | -56.25 | 31.53 | 16.11 |
Free Cash Flow Growth | - | - | - | 95.72% | - |
Free Cash Flow Margin | 4.92% | -29.85% | -15.82% | 8.11% | 7.33% |
Free Cash Flow Per Share | 0.25 | -1.55 | -1.23 | 0.69 | 0.39 |
Cash Interest Paid | 19.03 | 15.19 | 20.91 | 17.28 | 5.12 |
Cash Income Tax Paid | -0.31 | 12.89 | 7.61 | 7.97 | 11.8 |
Levered Free Cash Flow | -37.43 | -31.19 | -72.02 | -75.91 | 7.05 |
Unlevered Free Cash Flow | -25.14 | -18.28 | -56.89 | -66.73 | 7.31 |
Change in Working Capital | 18.88 | -9.19 | -91.17 | -3.02 | -1.65 |